ZSWIM8 Antibodies

Santa Cruz Biotechnology features a diverse variety of ZSWIM8 monoclonal antibodies for research focused on understanding ZSWIM8 protein functions. ZSWIM8 monoclonal antibodies are validated for multiple applications, including western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), immunohistochemistry with paraffin-embedded sections (IHCP), flow cytometry (FCM), and enzyme-linked immunosorbent assay (ELISA). ZSWIM8 is a member of the SWIM (SWI/SNF-related, matrix-associated, actin-dependent regulator of chromatin) domain-containing protein family, which participates in various cellular processes, including transcription regulation and DNA repair. ZSWIM8 plays a crucial role in modulating gene expression and maintaining genomic stability, making it an important target for studies related to cancer and other diseases. Understanding ZSWIM8 function can provide insights into its potential as a therapeutic target. Researchers can explore ZSWIM8 expression patterns across different tissues and cell types using multiple detection methods. Advanced visualization techniques enable detailed examination of ZSWIM8 localization and interactions within cellular compartments. Investigating ZSWIM8's role in disease mechanisms may reveal new therapeutic strategies. Santa Cruz Biotechnology monoclonal antibodies support scientific advancement by enabling precise detection and analysis of ZSWIM8 in biomedical research.